Khan, S.; Marquez-Martinez, S.; Erkens, T.; de Wilde, A.; Costes, L.M.M.; Vinken, P.; De Jonghe, S.; Roosen, W.; Talia, C.; Chamanza, R.;
et al. Intravenous Administration of Ad26.COV2.S Does Not Induce Thrombocytopenia or Thrombotic Events or Affect SARS-CoV-2 Spike Protein Bioavailability in Blood Compared with Intramuscular Vaccination in Rabbits. Vaccines 2023, 11, 1792.
https://doi.org/10.3390/vaccines11121792
AMA Style
Khan S, Marquez-Martinez S, Erkens T, de Wilde A, Costes LMM, Vinken P, De Jonghe S, Roosen W, Talia C, Chamanza R,
et al. Intravenous Administration of Ad26.COV2.S Does Not Induce Thrombocytopenia or Thrombotic Events or Affect SARS-CoV-2 Spike Protein Bioavailability in Blood Compared with Intramuscular Vaccination in Rabbits. Vaccines. 2023; 11(12):1792.
https://doi.org/10.3390/vaccines11121792
Chicago/Turabian Style
Khan, Selina, Sonia Marquez-Martinez, Tim Erkens, Adriaan de Wilde, Lea M. M. Costes, Petra Vinken, Sandra De Jonghe, Wendy Roosen, Chiara Talia, Ronnie Chamanza,
and et al. 2023. "Intravenous Administration of Ad26.COV2.S Does Not Induce Thrombocytopenia or Thrombotic Events or Affect SARS-CoV-2 Spike Protein Bioavailability in Blood Compared with Intramuscular Vaccination in Rabbits" Vaccines 11, no. 12: 1792.
https://doi.org/10.3390/vaccines11121792
APA Style
Khan, S., Marquez-Martinez, S., Erkens, T., de Wilde, A., Costes, L. M. M., Vinken, P., De Jonghe, S., Roosen, W., Talia, C., Chamanza, R., Serroyen, J., Tolboom, J., Zahn, R. C., & Wegmann, F.
(2023). Intravenous Administration of Ad26.COV2.S Does Not Induce Thrombocytopenia or Thrombotic Events or Affect SARS-CoV-2 Spike Protein Bioavailability in Blood Compared with Intramuscular Vaccination in Rabbits. Vaccines, 11(12), 1792.
https://doi.org/10.3390/vaccines11121792
